Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by wrongturnon Jul 08, 2010 5:59pm
370 Views
Post# 17255131

RE: voclo lux tangle

RE: voclo lux tangleAntoninus,

Having experience in the transplant field is probably why Lux's mgmt does not want to enter that field.  It's controlled tightly by the big players and tough to break into without a ground breaking drug.  Voclo is only marginally better on a variety of levels.  I think Lux wants to move the drug forward for their own benefit.  (These are only my thoughts).

The spoiler is Paladin, who has everything to gain by slowing down the process.

What Foster could do to raise funds, and I'm not saying this is going to work, is to offer warrants to long time shareholders or to individuals with larger blocks of shares.  (Give me a chance to purchase 100,000 shares at ten cents per share and I will definitely think about it).  Gives the longs a chance to average down, it would make me a little happier since I've been carrying this thing for so long, and it raises needed cash for the company.  Almost a win win....
<< Previous
Bullboard Posts
Next >>